Kovack Advisors, Inc. Eli Lilly & CO Transaction History

Kovack Advisors, Inc.

$919 Million
Q3 2024

A detailed history of Kovack Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Kovack Advisors, Inc. holds 4,956 shares of LLY stock, worth $3.81 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

4,956

Previous 4,516 9.74%

Holding current value

$3.81 Million

Previous $4.09 Million 7.39%

% of portfolio

0.48%

Previous 0.46%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $339,741 - $422,408	440 Added 9.74%	4,956 $4.39 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $104,381 - $130,901	-144 Reduced 3.09%	4,516 $4.09 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $53,890 - $72,097	-91 Reduced 1.92%	4,660 $3.63 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $457,965 - $539,881	872 Added 22.48%	4,751 $2.77 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $222,131 - $306,242	511 Added 15.17%	3,879 $2.08 Million
Q2 2023 Jul 21, 2023	BUY	$350.74 - $468.98 $193,959 - $259,345	553 Added 19.64%	3,368 $1.58 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $31,063 - $36,482	-100 Reduced 3.43%	2,815 $966,000
Q4 2022 Feb 22, 2023	SELL	$321.55 - $374.67 $9,646 - $11,240	-30 Reduced 1.02%	2,915 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $873,133 - $995,027	2,945 New	2,945 $952,000
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $932,073 - $1.09 Million	-3,344 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $122,508 - $152,246	-522 Reduced 13.5%	3,344 $957,000
Q4 2021 Jan 18, 2022	SELL	$224.85 - $279.04 $56,437 - $70,039	-251 Reduced 6.1%	3,866 $1.07 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $14,847 - $18,271	-67 Reduced 1.6%	4,117 $951,000
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $34,123 - $44,139	189 Added 4.73%	4,184 $960,000
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $18,732 - $24,250	114 Added 2.94%	3,995 $746,000
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $109,064 - $144,318	-836 Reduced 17.72%	3,881 $655,000
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $27,635 - $31,965	189 Added 4.17%	4,717 $698,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $71,347 - $85,866	523 Added 13.06%	4,528 $743,000
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $17,500 - $21,660	147 Added 3.81%	4,005 $556,000
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $25,446 - $31,518	-238 Reduced 5.81%	3,858 $507,000
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $12,387 - $13,474	-116 Reduced 2.75%	4,096 $458,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $41,103 - $47,977	-371 Reduced 8.1%	4,212 $467,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $64,893 - $76,384	-583 Reduced 11.29%	4,583 $595,000
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $94,886 - $106,301	896 Added 20.98%	5,166 $598,000
Q3 2018 Oct 09, 2018	BUY	$85.86 - $107.31 $366,622 - $458,213	4,270 New	4,270 $458,000
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $315,139 - $361,681	-4,163 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $20,110 - $23,739	271 Added 6.96%	4,163 $322,000
Q4 2017 May 15, 2018	SELL	$81.94 - $87.89 $24,663 - $26,454	-301 Reduced 7.18%	3,892 $329,000
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $343,574 - $368,522	4,193 New	4,193 $354,000
Q2 2017 Aug 30, 2018	SELL	N/A	-2,490 Closed	0 $0
Q1 2017 Sep 05, 2018	SELL	N/A	-2,475 Reduced 49.85%	2,490 $209,000
Q4 2016 Sep 10, 2018	BUY	N/A	4,965	4,965 $365,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Eli Lilly & CO Transaction History